TOday’s Movers: Parexel (NASDAQ:PRXL) Stock Rating Reiterated at Jefferies; $88.1 Target Price Indicates 0.17 % Potential

September 17, 2017 - By Hazel Jackson

 TOday’s Movers: Parexel (NASDAQ:PRXL) Stock Rating Reiterated at Jefferies; $88.1 Target Price Indicates 0.17 % Potential

Investors sentiment decreased to 0.85 in Q4 2016. Its down 0.15, from 1 in 2016Q3. It is negative, as 51 investors sold PAREXEL International Corporation shares while 100 reduced holdings. 46 funds opened positions while 83 raised stakes. 47.26 million shares or 0.12% more from 47.20 million shares in 2016Q3 were reported.

Parametric Portfolio Limited Liability Com invested 0.01% in PAREXEL International Corporation (NASDAQ:PRXL). Thrivent For Lutherans invested in 0% or 9,130 shares. Phocas has invested 0.32% of its portfolio in PAREXEL International Corporation (NASDAQ:PRXL). Tealwood Asset Mngmt invested 0.78% of its portfolio in PAREXEL International Corporation (NASDAQ:PRXL). 24,861 were accumulated by Mason Street Advsr Ltd Liability. Employees Retirement Of Texas owns 56,000 shares for 0.05% of their portfolio. Whittier Of Nevada Incorporated holds 494 shares. Moreover, Scotia Incorporated has 0% invested in PAREXEL International Corporation (NASDAQ:PRXL) for 3,950 shares. Piermont Management reported 13,890 shares. Gareth Morgan Invs Partnership reported 0.14% stake. Glob X Mngmt Lc holds 3,641 shares. Clearbridge Investments Lc accumulated 1.02M shares or 0.07% of the stock. Moreover, Aristotle Boston Limited Liability Com has 1.75% invested in PAREXEL International Corporation (NASDAQ:PRXL). Fifth Third Savings Bank holds 0% in PAREXEL International Corporation (NASDAQ:PRXL) or 4 shares. Price T Rowe Associates Md reported 347,205 shares.

Parexel (NASDAQ:PRXL) Rating Reaffirmed

In a research report shared with investors this morning, Jefferies kept their Hold rating on Parexel (NASDAQ:PRXL) shares. The target price would suggest a possible upside of 0.17 % from firm’s current stock price.

Investors sentiment decreased to 0.85 in Q4 2016. Its down 0.15, from 1 in 2016Q3. It is negative, as 51 investors sold PAREXEL International Corporation shares while 100 reduced holdings. 46 funds opened positions while 83 raised stakes. 47.26 million shares or 0.12% more from 47.20 million shares in 2016Q3 were reported.

Parametric Portfolio Limited Liability Com invested 0.01% in PAREXEL International Corporation (NASDAQ:PRXL). Thrivent For Lutherans invested in 0% or 9,130 shares. Phocas has invested 0.32% of its portfolio in PAREXEL International Corporation (NASDAQ:PRXL). Tealwood Asset Mngmt invested 0.78% of its portfolio in PAREXEL International Corporation (NASDAQ:PRXL). 24,861 were accumulated by Mason Street Advsr Ltd Liability. Employees Retirement Of Texas owns 56,000 shares for 0.05% of their portfolio. Whittier Of Nevada Incorporated holds 494 shares. Moreover, Scotia Incorporated has 0% invested in PAREXEL International Corporation (NASDAQ:PRXL) for 3,950 shares. Piermont Management reported 13,890 shares. Gareth Morgan Invs Partnership reported 0.14% stake. Glob X Mngmt Lc holds 3,641 shares. Clearbridge Investments Lc accumulated 1.02M shares or 0.07% of the stock. Moreover, Aristotle Boston Limited Liability Com has 1.75% invested in PAREXEL International Corporation (NASDAQ:PRXL). Fifth Third Savings Bank holds 0% in PAREXEL International Corporation (NASDAQ:PRXL) or 4 shares. Price T Rowe Associates Md reported 347,205 shares.

PAREXEL International Corporation (NASDAQ:PRXL) Ratings Coverage

Among 17 analysts covering Parexel International (NASDAQ:PRXL), 1 have Buy rating, 3 Sell and 13 Hold. Therefore 6% are positive. Parexel International has $88.1000 highest and $49 lowest target. $70.64’s average target is -19.68% below currents $87.95 stock price. Parexel International had 38 analyst reports since August 7, 2015 according to SRatingsIntel. William Blair downgraded the stock to “Market Perform” rating in Monday, July 18 report. The stock of PAREXEL International Corporation (NASDAQ:PRXL) has “Sell” rating given on Friday, December 16 by Goldman Sachs. The stock of PAREXEL International Corporation (NASDAQ:PRXL) has “Underperform” rating given on Monday, April 11 by Avondale. The firm has “Outperform” rating by Credit Suisse given on Tuesday, June 21. The rating was upgraded by SunTrust on Monday, March 28 to “Buy”. Evercore upgraded the shares of PRXL in report on Monday, May 15 to “Outperform” rating. Deutsche Bank maintained the shares of PRXL in report on Friday, August 7 with “Hold” rating. The rating was downgraded by Avondale on Monday, January 25 to “Mkt Underperform”. The stock has “Hold” rating by Evercore on Wednesday, January 4. Credit Suisse maintained the stock with “Outperform” rating in Friday, August 7 report.

The stock increased 0.02% or $0.02 on September 15, reaching $87.95. About 798,422 shares traded or 13.22% up from the average. PAREXEL International Corporation (NASDAQ:PRXL) has risen 35.35% since September 17, 2016 and is uptrending. It has outperformed by 18.65% the S&P500.

Wall Street await PAREXEL International Corporation (NASDAQ:PRXL) to release earnings on October, 25. Analysts forecast EPS of $0.89, up exactly $0.13 or 17.11 % from 2014’s $0.76 EPS. The expected PRXL’s profit could reach $45.54 million giving the stock 24.71 P/E in the case that $0.89 earnings per share is reported. After posting $1.02 EPS for the previous quarter, PAREXEL International Corporation’s analysts now forecast -12.75 % negative EPS growth.

PAREXEL International Corporation is a biopharmaceutical outsourcing services company. The company has market cap of $4.50 billion. The Firm provides a range of expertise in clinical research, clinical logistics, medical communications, consulting, commercialization, and technology services and products to pharmaceutical, biotechnology and medical device industries. It has a 42.82 P/E ratio. The Company’s divisions include Clinical Research Services (CRS), PAREXEL Consulting Services (PC) and PAREXEL Informatics (PI).

More notable recent PAREXEL International Corporation (NASDAQ:PRXL) news were published by: Businesswire.com which released: “PAREXEL International Reports Fourth Quarter and Fiscal Year 2017 Results” on August 28, 2017, also Seekingalpha.com with their article: “Upside Potential From Possible Transaction At PAREXEL International” published on May 25, 2017, Reuters.com published: “Contract research firm Parexel International explores sale: sources” on May 08, 2017. More interesting news about PAREXEL International Corporation (NASDAQ:PRXL) were released by: Businesswire.com and their article: “PAREXEL and Osaka International Cancer Institute Form Alliance to Advance …” published on August 21, 2017 as well as Reuters.com‘s news article titled: “Pamplona Capital to take Parexel private for $4.5 billion” with publication date: June 20, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.